**Core Concept:** Elevated triglycerides and decreased HDL are key components of the Metabolic Syndrome (MetS), a cluster of interrelated risk factors for cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM). Triglycerides are a type of lipid, and HDL is a type of cholesterol. Both are essential components of blood lipid profile.

**Why the Correct Answer is Right:** Metabolic Syndrome is characterized by a combination of risk factors, including visceral obesity, insulin resistance, hypertension, and dyslipidemia. In this case, the focus is on the dyslipidemia aspect. Elevated triglycerides (TG) are associated with increased production, reduced clearance, or both, leading to high levels in the blood. High triglycerides promote inflammation, oxidative stress, and endothelial dysfunction, contributing to CVD and T2DM. Low HDL cholesterol (HDL-C) is a result of reduced lipoprotein lipase (LPL) activity, leading to decreased HDL synthesis and clearance. Low HDL-C is a risk factor for CVD as it contributes to the formation of atherogenic lipoproteins like VLDL and LDL.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because it does not encompass the entirety of Metabolic Syndrome, focusing only on elevated triglycerides.
B. This option is incorrect because it is a single component of Metabolic Syndrome and does not address the relationship between dyslipidemia and the Metabolic Syndrome.
C. This option is incorrect because it focuses on a single risk factor and does not address the relationship between dyslipidemia and the Metabolic Syndrome.
D. This option is incorrect as it deals with insulin resistance, which is one of the components of Metabolic Syndrome, but does not address the relationship between dyslipidemia and Metabolic Syndrome.

**Clinical Pearl:** The Metabolic Syndrome is a significant predisposing factor for cardiovascular events and type 2 diabetes. Regular health check-ups and lifestyle modifications, such as exercise and diet, can help lower the risk of developing Metabolic Syndrome and its complications. Early detection and intervention can lead to improved health outcomes.